This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CCG Investor Relations Announces Company Presenters For NexGen Life Sciences Virtual Conference

NEW YORK, Sept. 11, 2013 /PRNewswire/ -- CCG Investor Relations, a leading global investor relations and strategic communications consultancy, is pleased to announce the companies who will present their investment stories as part of the Life Sciences Virtual Investment Conference to be held on Thursday, September 12, 2013.

The NexGen Life Science Virtual Investment Conference is organized by CCG Investor Relations and co-hosted by  BetterInvesting, and  PR Newswire.  The event is designed to provide retail investors, institutional investors, financial advisors and family offices with a road map as to how scientific breakthroughs move through the process towards commercialization, including FDA trials, partnerships, distribution agreements and coverage by health insurance and Medicare.

The virtual conference is free for both retail and institutional investors to attend.  To register, please visit

Crocker Coulson of CCG Investor Relations will interview Andrew Fein, Managing Director & Senior Analyst at H.C. Wainwright on a panel on NexGen Drugs and Global CROs from 9am to 10am.

The presenting schedule for the conference is as follows:

08:15 a.m. ETBioLight Israeli Life Sciences Investments Ltd (TASE: BOLT), Suzana Bar-Natan, CEO

09:00 a.m. ET: Analyst Discussion with Andrew Fein: NextGen Drugs and Global CROs

10:15 a.m. ET:  Del Mar Pharmaceuticals Inc (OTCBB: DMPI)  

11:00 a.m. ET: Organovo (NYSE: ONVO)

11:45 a.m. ET: Bone Biologics

12:30 p.m. ET: Advanced Bifurcation Systems        

"A new wave of innovation is sweeping the life sciences sector, creating the opportunity for new therapies that save lives or improve patient care, while offering exceptional returns for investors, who employ thoughtful stock selection," said Crocker Coulson, President of CCG. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs